HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alfonso Bueno-Orovio Selected Research

Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)

1/2024Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy.
12/2022Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy.
11/2022Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy.
5/2022Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function.
11/2019Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: A Translational Study.
1/2016Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alfonso Bueno-Orovio Research Topics

Disease

6Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2024 - 01/2016
4Atrial Fibrillation
01/2022 - 01/2016
3Heart Failure
01/2024 - 02/2014
2Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 01/2022
2Fibrosis (Cirrhosis)
01/2023 - 06/2022
2Cardiac Arrhythmias (Arrythmia)
02/2021 - 01/2016
2Cardiotoxicity
01/2021 - 01/2020
1Ventricular Tachycardia
01/2024
1Disease Progression
01/2023
1Cicatrix (Scar)
06/2022
1Myocardial Infarction
01/2022
1Heart Neoplasms
03/2020
1Heart Diseases (Heart Disease)
01/2020
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2019
1Torsades de Pointes (Torsade de Pointes)
01/2019
1Ischemia
02/2014

Drug/Important Bio-Agent (IBA)

3Anti-Arrhythmia AgentsIBA
11/2019 - 01/2016
2omega-Chloroacetophenone (Mace)IBA
01/2024 - 01/2022
2CollagenIBA
01/2023 - 06/2022
2Proteins (Proteins, Gene)FDA Link
12/2022 - 01/2021
2Adrenergic Agents (Adrenergic Drugs)IBA
11/2022 - 05/2022
2SodiumIBA
02/2021 - 12/2016
1RanolazineFDA Link
01/2024
1Potassium Channels (Potassium Channel)IBA
01/2023
1PotassiumIBA
11/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Anti-Infective Agents (Microbicides)IBA
01/2021
1SolutionsIBA
03/2020
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2020
1Disopyramide (Norpace)FDA LinkGeneric
11/2019
1Ion Channels (Ion Channel)IBA
01/2019
1CalciumIBA
12/2016
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
01/2016
1DystrophinIBA
01/2016
1Sodium-Potassium-Exchanging ATPase (Sodium, Potassium ATPase)IBA
02/2014

Therapy/Procedure

3Therapeutics
12/2022 - 01/2016
1Precision Medicine
01/2022